Cargando…

Outcomes and Prognostic Factors in Critical Patients with Hematologic Malignancies

Patients with hematologic malignancies (HMs) have a significantly elevated risk of mortality compared to other cancer patients treated in the intensive care unit (ICU). The prognostic impact of numerous poor outcome indicators has changed, and research has yielded conflicting results. This study aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chieh-Lung, Wang, Sing-Ting, Cheng, Wen-Chien, Wu, Biing-Ru, Liao, Wei-Chih, Hsu, Wu-Huei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918099/ https://www.ncbi.nlm.nih.gov/pubmed/36769606 http://dx.doi.org/10.3390/jcm12030958

Ejemplares similares

Endobronchial Ultrasound Changed the World of Lung Cancer Patients: A 11-Year Institutional Experience
por: Chen, Chia-Hung, et al.
Publicado: (2015)

Interventional pulmonology for patients with central airway obstruction: An 8-year institutional experience
por: Chen, Chia-Hung, et al.
Publicado: (2017)

When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment
por: Cheng, Wen-Chien, et al.
Publicado: (2020)

Outcome Prediction of Hematologic Malignancy in Critically Sick People
por: Velmurugan, Palanivel, et al.
Publicado: (2022)

Predictors of poor outcomes in critically ill patients with hematologic malignancy
por: Cornish, M, et al.
Publicado: (2015)

Predictors of Poor Outcomes in Critically Ill Adults with Hematologic Malignancy
por: Cornish, Marion, et al.
Publicado: (2016)

Feasibility and Safety of Pleuroscopic Cryobiopsy of the Pleura: A Prospective Study
por: Chen, Chia-Hung, et al.
Publicado: (2018)

Long Term Surgical Outcome and Prognostic Factors of Atypical and Malignant Meningiomas
por: Wang, Yu-Chi, et al.
Publicado: (2016)

Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
por: Chen, Chien-Yuan, et al.
Publicado: (2018)

Clinical characteristics and outcomes of Mycobacterium tuberculosis disease in adult patients with hematological malignancies
por: Chen, Chien-Yuan, et al.
Publicado: (2011)

The prognostic factors for patients with hematological malignancies admitted to the intensive care unit
por: Cheng, Qian, et al.
Publicado: (2016)

A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease
por: Huang, Wei-Chun, et al.
Publicado: (2021)

Differences in Pulmonary Function Improvement after Once-Daily LABA/LAMA Fixed-Dose Combinations in Patients with COPD
por: Huang, Wei-Chun, et al.
Publicado: (2022)

Comparison of the effects of the three major tyrosine kinase inhibitors as first-line therapy for non-small-cell lung cancer harboring epidermal growth factor receptor mutations
por: Tu, Chih-Yen, et al.
Publicado: (2018)

Clinical Application of Metagenomic Next-Generation Sequencing in Patients with Hematologic Malignancies Suffering from Sepsis
por: Liu, Wang-Da, et al.
Publicado: (2021)

Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies
por: D'Arena, Giovanni, et al.
Publicado: (2017)

Invasive aspergillosis in critically ill hematology patients: outcomes and prognostic factors associated with mortality
por: Burghi, G, et al.
Publicado: (2011)

Risk Factors and Outcomes in Critically Ill Patients with Hematological Malignancies Complicated by Hospital-Acquired Infections
por: Yerzhan, Adina, et al.
Publicado: (2023)

Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies
por: Salih, Zena, et al.
Publicado: (2013)

Critical Role of Aquaporins in Cancer: Focus on Hematological Malignancies
por: Allegra, Alessandro, et al.
Publicado: (2022)

Microbiology and prognostic prediction model of bloodstream infection in patients with hematological malignancies
por: Wang, Jinjin, et al.
Publicado: (2023)

Deubiquitinases in hematological malignancies
por: Lei, Hu, et al.
Publicado: (2021)

Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies
por: Chen, Chien-Yuan, et al.
Publicado: (2019)

Using real-time visualization system for data-driven decision support to achieve lung protective strategy: a retrospective observational study
por: Tseng, How-Yang, et al.
Publicado: (2022)

CD markers polymorphisms as prognostic biomarkers in hematological malignancies
por: Shahrabi, Saeid, et al.
Publicado: (2020)

Prognostic significance of isochromosome 17q in hematologic malignancies
por: Koczkodaj, Dorota, et al.
Publicado: (2021)

New Clues to Prognostic Biomarkers of Four Hematological Malignancies
por: Salifu, Samson Pandam, et al.
Publicado: (2022)

Outcomes and Risk Factors of Critically Ill Patients with Hematological Malignancy. Prospective Single-Centre Observational Study
por: Judickas, Šarūnas, et al.
Publicado: (2021)

Outcomes of Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies
por: Chien, Kelly S., et al.
Publicado: (2022)

Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies
por: Chien, Kelly S., et al.
Publicado: (2023)

Intracranial hemorrhage in adult patients with hematological malignancies
por: Chen, Chien-Yuan, et al.
Publicado: (2012)

Statin Therapy and the Risk of Viral Infection: A Retrospective Population-Based Cohort Study
por: Wu, Biing-Ru, et al.
Publicado: (2022)

Liver resection for hepatocellular carcinoma in patients with hematological malignancies
por: Lin, Hui-Chen, et al.
Publicado: (2017)

When to add anti-angiogenesis drugs to EGFR-mutated metastatic non–small cell lung cancer patients: a real-world study from Taiwan
por: Chen, Chieh-Lung, et al.
Publicado: (2022)

A real-world study comparing perioperative chemotherapy and EGFR-tyrosine kinase inhibitors for treatment of resected stage III EGFR-mutant adenocarcinoma
por: Chen, Chieh-Lung, et al.
Publicado: (2023)

Super-enhancers: critical roles and therapeutic targets in hematologic malignancies
por: Jia, Yunlu, et al.
Publicado: (2019)

Resource use and outcome in critically ill patients with hematological malignancy: a retrospective cohort study
por: Merz, Tobias M, et al.
Publicado: (2008)

Hematopoiesis and microenvironment in hematological malignancies
por: Cheng, Hui, et al.
Publicado: (2018)

Addendum: Prognostic significance of isochromosome 17q in hematologic malignancies
por: Koczkodaj, Dorota, et al.
Publicado: (2023)

De novo thymic carcinoma or malignant transformation: a myasthenic patient presented with multiple mediastinal tumours
por: Pai, Chu‐Pin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lrn16jr9sjjv8f8hd1qucek8f5